Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|March 26, 2014
Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receiptJennifer M Polinski, M Alan Brookhart, John Z Ayanian, et al.
JAMA Network Open|August 1, 2019
Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee ReplacementSeoyoung C Kim, Yinzhu Jin, Yvonne C Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2019
Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort StudyRishi J Desai, Yinzhu Jin, Patricia D Franklin, et al.
Arthritis Care & Research|January 15, 2021
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee ReplacementChandrasekar Gopalakrishnan, Rishi J Desai, Jessica M Franklin, et al.
Archives of Internal Medicine|February 29, 2012
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trialDaniel H Solomon, Maura D Iversen, Jerry Avorn, et al.
Annals of the Rheumatic Diseases|November 17, 2012
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonistDaniel H Solomon, Jeremy A Rassen, Bindee Kuriya, et al.
Journal of the American College of Cardiology|October 9, 2012
The impact of reducing cardiovascular medication copayments on health spending and resource utilizationNiteesh K Choudhry, Michael A Fischer, Jerry L Avorn, et al.
Drug Safety|May 16, 2024
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020Mufaddal Mahesri, Ameet Sarpatwari, Krista F Huybrechts, et al.
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
BMJ (Clinical Research Ed.)|April 5, 2018
Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort studyRishi J Desai, Ameet Sarpatwari, Sara Dejene, et al.
Pageof 6